A potential rate hike weighed the markets down to a lower close with the Dow falling 53 points to 18,395. Nasdaq rose 6 points to 5,218.
On the upside
Analysts expect Adamis Pharmaceuticals's (Nasdaq: ADMP) generic pre-filled epinephrine syringe, EpiPen, will be approved soon.
Bottomline Technologies (Nasdaq: EPAY) narrowed fourth quarter losses more than expected and announced a $60 million stock repurchase program.
Fiesta Restaurant Group (Nasdaq: FRGI) chief executive Tim Taft will retire at the end of the year.
On the downside
Fourth quarter earnings and revenue fell short for Aceto (Nasdaq: ACET).
GameStop (NYSE: GME) disappointed with lower second quarter revenue that missed expectations.
Ferroglobe (Nasdaq: GSM) reported a loss for the second quarter.
In the broad market, declining issues outpaced advancers by a margin of more than 3 to 2 on the NYSE and by nearly 10 to 9 on Nasdaq. The broader S&P 500 rose 3 points to 2,169. Bitcoin added $1 to $576.
